Regeneron signs $3B manufacturing agreement with Fujifilm Diosynth in North Carolina

Regeneron has announced a new manufacturing and supply agreement with FUJIFILM Diosynth Biotechnologies to produce bulk drug product at their Holly Springs, North Carolina campus. The total investment is estimated to exceed $3 billion over a ten-year term.

“Regeneron today announced a significant expansion of its manufacturing capacity through a new agreement with FUJIFILM Diosynth Biotechnologies to manufacture and supply bulk drug product of Regeneron’s commercial biologic medicines at their Holly Springs, North Carolina campus.”investor.regeneron.com

• 1 source
• investor.regeneron.comRegeneron Announces New Investment in Manufacturing of ...Apr 22, 2025

Summarized from public sources; check the original articles before acting on it.